Mapping Analogous Heterogens onto Residue Interaction

At the interface of structural bioinformatics, probe molecules, and fragment based drug discovery

Based on existing protein-ligand crystal structures in the PDB.

All you need to know about your fragment interaction.

Your ligand with SNPs and pathways.

MAHORI is now replaced with MANORAA